Cingulate Inc. (CING) vs InterCure Ltd. (INCR)
A side-by-side comparison of Cingulate Inc. and InterCure Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CING
Cingulate Inc.
$4.89HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
INCR
InterCure Ltd.
$5.32HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CING vs INCR
growth of $100 · dividends reinvested · last 5yCING -99.6% (-66.1%/yr)INCR -85.1% (-31.7%/yr)INCR compounded faster over this window
Log scale — wide-divergence pair
CING INCR
CING vs INCR: by the numbers
- •CING is the larger company ($66M vs $63M market cap).
- •Both run net losses; CING's is the smaller (0.00% vs -13.72% net margin).
Metrics side by side
Valuation
| Metric | CING | INCR |
|---|---|---|
| P/S ratio | N/A | 0.79 |
| P/B ratio | 2.81 | 0.51 |
| EV / EBITDA | 0.22 | N/A |
| FCF yield | N/A | 11.66% |
Profitability
| Metric | CING | INCR |
|---|---|---|
| Gross margin | 0.00% | 14.40% |
| Operating margin | 0.00% | 2.49% |
| Net margin | 0.00% | -13.72% |
| ROE | -122.71% | -8.80% |
| ROIC | -83.74% | -4.72% |
Growth (annualized)
| Metric | CING | INCR |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 32.71% |
| Total return CAGR (5Y) | N/A | -30.85% |
Go deeper
Dig into the metrics
Cingulate ROEInterCure ROECingulate operating marginInterCure operating marginCingulate revenue growthInterCure revenue growthCingulate free cash flowInterCure free cash flow
Cingulate & InterCure appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.